<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Increased <z:chebi fb="1" ids="50211">retinol</z:chebi>-binding protein 4 (RBP4) has been reported in association with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to investigate the association of serum RBP4 with impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> in Chinese adults aged 40 years or older </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Serum RBP4 was measured in 763 individuals with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation, 508 with impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and 524 newly diagnosed diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain>Serum RBP4 was measured using ELISA and urine albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio was used to determine the urinary albumin excretion </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Serum RBP4 concentrations were significantly higher in participants with isolated impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, isolated <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, combined impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>/<z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> than in those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation, whereas serum RBP4 levels were not different in the four groups with dysregulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="5" pm="."><plain>RBP4 was associated with a higher risk for impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation (OR 1.011 for each 1 microg/ml increase in RBP4, 95% CI 1.000-1.022, p = 0.04) after adjustment for sex, age, BMI, current smoking and alcohol intake, family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, triacylglycerol, total cholesterol, and <z:chebi fb="17" ids="39025">HDL</z:chebi>- and <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>; the corresponding OR of combined impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was 1.022 (95% CI 1.009-1.035, p = 0.0009) </plain></SENT>
<SENT sid="6" pm="."><plain>RBP4 was associated with the risk of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (OR 1.023, 95% CI 1.004-1.042, p = 0.01) after adjustment for sex, age, smoking habit and alcohol intake, BMI, waist/hip ratio, homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, GFR, triacylglycerol, total cholesterol, and <z:chebi fb="17" ids="39025">HDL</z:chebi>- and <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: Serum RBP4 level is closely associated with impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and is an independent risk factor for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
</text></document>